Evidence map›Paper›PMID 40441861›Full record

ArticleJournal of biomedical research2026

Mechanisms and targets of harnessing

Xuebin Zhao, Jian Zheng, Weimin Zheng, Jinrong Lin, Guangshuo Ding, Xinhui Yu, Jun Cao, Yun Chen, Bo Shen, Gaoqian Feng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of biomedical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Editorial commentary on the special issue of immunology.Journal of biomedical research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xuebin ZhaoNational Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Jian ZhengNational Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Weimin ZhengThe Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu 225300, China.
Jinrong LinNational Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Guangshuo DingJiangsu Key Laboratory of Pathogen Biology, Department of Pathogenic Biology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Xinhui YuNational Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Jun CaoKey Laboratory of National Health Commission on Parasitic Disease Control and Prevention, Key Laboratory of Jiangsu Province on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu 214064, China.
Yun ChenState Key Laboratory of Reproductive Medicine and Offspring Health, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Bo ShenJiangsu Key Laboratory of Pathogen Biology, Department of Pathogenic Biology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Gaoqian FengNational Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mosquito-borne diseases pose a significant global health threat, necessitating the development of innovative vector control strategies. In this study, we investigated the potential of harnessing host immunity against mosquitoes through vaccination. Using

Indexed as

antibodiesclassical complement pathwayCulexmosquito controloviposition

Identifiers

PMID40441861
PMCPMC13044400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.